<p>Upstream process development is a critical step in ensuring that the needed protein quality is met on a large scale. However, due to the inherent properties of the selected clone, the Research Production Cell Banks, which are derived mainly based on initial high productivity, frequently delay the subsequent process development. In the cell line development stage, we recently used the CHOZN-GS system to apply our quality-driven Fc-fusion protein screening procedures to select appropriate clones that ranged in the target product quality. Our strategies can also be used as an enhanced cell line development platform with high titer and developability.</p>
<p><b>In this webinar, you will learn:</b></p>
<ul>
<li>Quality-driven screening procedures on various Fc-fusion protein</li>
<li>Enhanced target clone selection methods</li>
</ul>


aem-GridColumn aem-GridColumn--default--9

<br/><br/><h2 class="webinar-subtitle">WEBINAR</h2>

Quality Improvement in Cell Line Development

aem-GridColumn aem-GridColumn--default--9 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

aem-GridColumn aem-GridColumn--default--3 aem-GridColumn--offset--default--0 aem-GridColumn--default--none

CHOZN-GS system aids in quality-driven Fc-fusion protein screening for appropriate clone selection in cell line development.